Holders — by stockHoldings — by fund
SILVERARC CAPITAL MANAGEMENT, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001816307
$854.4M
disclosed book value
70
positions
8.3%
largest position share
Positions, as of 2026-09-30
top 70 of 70 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | KODKODIAK SCIENCES INC | 750,170 | $71.1M | 8.3% |
| 2 | CELCCELCUITY INC | 803,193 | $63.9M | 7.5% |
| 3 | COGTCOGENT BIOSCIENCES INC | 1.6M | $50.4M | 5.9% |
| 4 | URGNUROGEN PHARMA LTD | 1.1M | $46.7M | 5.5% |
| 5 | IMNMIMMUNOME INC | 2.1M | $45.0M | 5.3% |
| 6 | GLUEMONTE ROSA THERAPEUTICS INC | 3.1M | $37.1M | 4.3% |
| 7 | SGMTSAGIMET BIOSCIENCES INC | 3.7M | $37.0M | 4.3% |
| 8 | ASNDASCENDIS PHARMA A/S | 152,175 | $34.7M | 4.1% |
| 9 | RYTMRHYTHM PHARMACEUTICALS INC | 348,317 | $33.2M | 3.9% |
| 10 | BIIBBIOGEN INC | 112,790 | $25.5M | 3% |
| 11 | IMVTIMMUNOVANT INC | 624,055 | $21.1M | 2.5% |
| 12 | DNTHDIANTHUS THERAPEUTICS INC | 236,582 | $20.8M | 2.4% |
| 13 | ORKAORUKA THERAPEUTICS INC | 247,918 | $20.6M | 2.4% |
| 14 | ERASERASCA INC | 1.3M | $19.5M | 2.3% |
| 15 | ABVXABIVAX SA | 175,699 | $17.4M | 2% |
| 16 | CLDXCELLDEX THERAPEUTICS INC NEW | 487,589 | $15.8M | 1.8% |
| 17 | OVIDOVID THERAPEUTICS INC | 6.0M | $14.8M | 1.7% |
| 18 | SYRESPYRE THERAPEUTICS INC | 151,151 | $13.5M | 1.6% |
| 19 | DFTXDEFINIUM THERAPEUTICS INC | 345,946 | $13.2M | 1.5% |
| 20 | HLXCHELIX ACQUISITION CORP III | 1.2M | $12.8M | 1.5% |
| 21 | ALKSALKERMES PLC | 300,427 | $12.2M | 1.4% |
| 22 | CELLDEX THERAPEUTICS INC NEWCALL | 370,700 | $12.0M | 1.4% |
| 23 | CCCCC4 THERAPEUTICS INC | 3.5M | $11.5M | 1.3% |
| 24 | AVLNAVALYN PHARMACEUTICALS INC | 378,352 | $10.8M | 1.3% |
| 25 | ORIC PHARMACEUTICALS INCCALL | 702,400 | $9.5M | 1.1% |
| 26 | CERSCERUS CORP | 4.0M | $9.4M | 1.1% |
| 27 | ALXOALX ONCOLOGY HLDGS INC | 6.6M | $9.1M | 1.1% |
| 28 | ZBIOZENAS BIOPHARMA INC | 334,057 | $9.0M | 1.1% |
| 29 | CMPSCOMPASS PATHWAYS PLC | 717,356 | $8.9M | 1% |
| 30 | RNAQURAINIER ACQUISITION CORP | 853,875 | $8.7M | 1% |
| 31 | CGENCOMPUGEN LTD | 3.6M | $8.5M | 1% |
| 32 | SVRASAVARA INC | 1.5M | $7.8M | 0.9% |
| 33 | PCVXVAXCYTE INC | 125,080 | $7.1M | 0.8% |
| 34 | YARWYARROW BIOSCIENCE INC | 301,919 | $6.8M | 0.8% |
| 35 | IBIOIBIO INC | 5.4M | $6.3M | 0.7% |
| 36 | ARCTARCTURUS THERAPEUTICS HLDGS | 459,899 | $6.3M | 0.7% |
| 37 | MONTE ROSA THERAPEUTICS INCCALL | 525,000 | $6.3M | 0.7% |
| 38 | PRAXPRAXIS PRECISION MEDICINES I | 19,753 | $5.8M | 0.7% |
| 39 | KNSAKINIKSA PHARMACEUTICALS INTL | 75,697 | $5.6M | 0.7% |
| 40 | ELVNENLIVEN THERAPEUTICS INC | 121,452 | $5.6M | 0.7% |
| 41 | SLDBSOLID BIOSCIENCES INC | 760,337 | $5.5M | 0.6% |
| 42 | EVMNEVOMMUNE INC | 594,027 | $4.9M | 0.6% |
| 43 | SNDXSYNDAX PHARMACEUTICALS INC | 247,418 | $4.7M | 0.5% |
| 44 | BNTCBENITEC BIOPHARMA INC | 443,109 | $4.4M | 0.5% |
| 45 | RACCRESEARCH ALLIANCE CORP III | 404,728 | $4.4M | 0.5% |
| 46 | BLSMBLOSSOMHILL THERAPEUTICS INC | 202,104 | $3.8M | 0.4% |
| 47 | FTHFAETH THERAPEUTICS INC | 124,098 | $3.7M | 0.4% |
| 48 | ABEOABEONA THERAPEUTICS INC | 693,441 | $3.6M | 0.4% |
| 49 | RACDRESEARCH ALLIANCE CORP IV | 301,962 | $3.5M | 0.4% |
| 50 | ANLADLAI NORTYE GROUP LTD | 216,617 | $3.5M | 0.4% |
| 51 | PALIPALISADE BIO INC | 2.3M | $3.2M | 0.4% |
| 52 | IRONDISC MEDICINE INC | 47,312 | $3.1M | 0.4% |
| 53 | ABSCI CORPORATIONPUT | 254,700 | $2.7M | 0.3% |
| 54 | TELATELA BIO INC | 2.1M | $2.5M | 0.3% |
| 55 | ZVRAZEVRA THERAPEUTICS INC | 200,260 | $2.2M | 0.3% |
| 56 | ORICORIC PHARMACEUTICALS INC | 160,552 | $2.2M | 0.3% |
| 57 | CTNMCONTINEUM THERAPEUTICS INC | 158,964 | $2.1M | 0.2% |
| 58 | MRNAMODERNA INC | 10,000 | $1.9M | 0.2% |
| 59 | ELUTELUTIA INC | 2.2M | $1.7M | 0.2% |
| 60 | FULCRUM THERAPEUTICS INCCALL | 391,900 | $1.5M | 0.2% |
| 61 | QUREUNIQURE NV | 56,704 | $1.4M | 0.2% |
| 62 | ACHVACHIEVE LIFE SCIENCE INC | 158,950 | $1.3M | 0.2% |
| 63 | ACRSACLARIS THERAPEUTICS INC | 238,541 | $1.3M | 0.1% |
| 64 | RAPPRAPPORT THERAPEUTICS INC | 35,524 | $1.2M | 0.1% |
| 65 | ZURA BIO LTDCALL | 242,200 | $1.0M | 0.1% |
| 66 | CAMPCAMP4 THERAPEUTICS CORP | 183,063 | $739,575 | 0.1% |
| 67 | ANNEXON INCCALL | 131,500 | $556,245 | 0.1% |
| 68 | ZURAZURA BIO LTD | 100,000 | $416,000 | 0% |
| 69 | CLRBCELLECTAR BIOSCIENCES INC | 151,118 | $278,057 | 0% |
| 70 | ADGMADAGIO MED HLDGS INC | 170,460 | $26,080 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.